This correction is made in compliance with Section 39n(3) of the Act and becomes effective on the day it is published on the official notice board. The List’s correction lays down the full list of medicinal products (MPs) and foods for special medicinal purposes (FSMPs) reimbursed from the public health insurance system subject to the Institute’s decision, including their maximum or announced ex-factory prices, the amount and the terms of reimbursement, incl. their highest possible reimbursement for the end consumer, along with the amount of the extra payment in the eligible limit. In addition, the List contains the basic reimbursements of reference groups and explains the reasoning behind the basic reimbursements, along with a full list of the medicinal products and foods for special medicinal purposes included in the reference groups.
In the published correction, the Institute corrected reimbursement price and conditions of reimbursement for pharmaceuticals included in the reference group No. 13/1 that were subjects of the administrative proceedings SUKLS265133/2012. The correction takes into account that the decision of SIDC of 30. 9. 2013 was abolished by the decision of the Ministry of Health of 22. 9. 2014. Reimbursement price and conditions of reimbursement of these pharmaceuticals were therefore brought back to the status prior to the decision of SIDC of 30. 9. 2013.
List of prices of medicinal products and fedical purposes
- SCAU141119.xls, soubor typu xls, (5,17 MB) - plný soubor s aktuálními úhradami